A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector

In the infectious diseases field, protective immunity against individual virus species or strains does not always confer cross-reactive immunity to closely related viruses, leaving individuals susceptible to disease after exposure to related virus species. This is a significant hurdle in the field o...

Full description

Bibliographic Details
Published in:	Vaccines
Main Authors:	Sarah Sebastian, Amy Flaxman, Kuan M. Cha, Marta Ulaszewska, Ciaran Gilbride, Hannah Sharpe, Edward Wright, Alexandra J. Spencer, Stuart Dowall, Roger Hewson, Sarah Gilbert, Teresa Lambe
Format:	Article
Language:	English
Published:	MDPI AG 2020-05-01
Subjects:	Ebola Marburg filovirus vaccine viral vector
Online Access:	https://www.mdpi.com/2076-393X/8/2/241

Similar Items

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Correlates of Immunity to Filovirus Infection
by: Sina Bavari, et al.
Published: (2011-06-01)

Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19
by: Marion F. Gruber, et al.
Published: (2023-02-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019-10-01)

Evolution of Ebola and Marburg Treatment Centers Design, a Review of the Last Ten Years of Outbreaks in Africa
by: Luca Fontana, et al.
Published: (2024-10-01)

Non-Ebola Filoviruses: Potential Threats to Global Health Security
by: Yannick Munyeku-Bazitama, et al.
Published: (2024-07-01)

Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)
by: Lindsay A. Parish, et al.
Published: (2023-06-01)

Animal models for Ebola and Marburg virus infections
by: Eri eNakayama, et al.
Published: (2013-09-01)

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
by: Daniel N. Wolfe, et al.
Published: (2020-11-01)

Selection of Filovirus Isolates for Vaccine Development Programs
by: Daniel N. Wolfe, et al.
Published: (2021-09-01)

Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents
by: Jinhong Chang, et al.
Published: (2013-01-01)

Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia
by: Katendi Changula, et al.
Published: (2021-06-01)

Standardization of the Filovirus Plaque Assay for Use in Preclinical Studies
by: Gene G. Olinger, et al.
Published: (2012-12-01)

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
by: Machteld M. Tiemessen, et al.
Published: (2022-08-01)

A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells
by: Corina M. Stewart, et al.
Published: (2019-03-01)

Marburg Virus Disease: A Narrative Review
by: Arash Letafati, et al.
Published: (2025-05-01)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01)

Two Distinct Lysosomal Targeting Strategies Afford Trojan Horse Antibodies With Pan-Filovirus Activity
by: Ariel S. Wirchnianski, et al.
Published: (2021-10-01)

Filoviruses in Bats: Current Knowledge and Future Directions
by: Kevin J. Olival, et al.
Published: (2014-04-01)

A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda
by: Luke Nyakarahuka, et al.
Published: (2020-07-01)

Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
by: Ariel Shepley-McTaggart, et al.
Published: (2021-02-01)

Vaccine Licensure in the Absence of Human Efficacy Data
by: Courtney L. Finch, et al.
Published: (2022-02-01)

Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID<sub>50</sub> Assays
by: Patrick T. Keiser, et al.
Published: (2021-01-01)

Periplasmic Nanobody-APEX2 Fusions Enable Facile Visualization of Ebola, Marburg, and Mĕnglà virus Nucleoproteins, Alluding to Similar Antigenic Landscapes among <i>Marburgvirus</i> and <i>Dianlovirus</i>
by: Laura J. Sherwood, et al.
Published: (2019-04-01)

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor
by: Rekha G. Panchal, et al.
Published: (2012-08-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

The Problematic Diseases of viral Hemorrhagic Fever: Insights into Ebola, Marburg, and Dengue Fever Viruses
by: Tharwat El-khamissy, et al.
Published: (2024-04-01)

New reverse sum Revan indices for physicochemical and pharmacokinetic properties of anti-filovirus drugs
by: W. Tamilarasi, et al.
Published: (2024-12-01)

Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene
by: Megan R. Edwards, et al.
Published: (2022-10-01)

A Call to Action to Enhance Filovirus Disease Outbreak Preparedness and Response
by: Paul Roddy
Published: (2014-09-01)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
by: Ryan P. Bennett, et al.
Published: (2020-12-01)

A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
by: Yuting Zhang, et al.
Published: (2024-03-01)

Outbreak of Marburg Virus Disease, Equatorial Guinea, 2023
by: Stephanie Ngai, et al.
Published: (2025-05-01)

A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control
by: George Y. Qian, et al.
Published: (2023-11-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
by: Anitha D. Jayaprakash, et al.
Published: (2023-01-01)

Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
by: Gene G. Olinger, et al.
Published: (2012-09-01)

Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study
by: George Y. Qian, et al.
Published: (2023-08-01)

Development of the Multiplex Real-Time PCR for Marburg, Ebola, and Lassa Viruses Identification
by: A. O. Sementsova, et al.
Published: (2011-06-01)

Marburg and Sudan viruses elicit divergent interferon responses and cytokine storm signaling in Egyptian rousette bat macrophages
by: Ivet A. Yordanova, et al.
Published: (2025-10-01)